Comparative Studies on the Postantifungal Effect of Cispentacin and Pradimicin (BMY-28864) on Candida albicans.
スポンサーリンク
概要
- 論文の詳細を見る
The in vitro postantifungal effect (PAFE) following exposure of Candia albicans to cispentacin and pradimicin (BMY-28864) for short periods of time was investigated. A turbidometric method was used to measure cell regrowth following exposure to different concentrations (0.313 to 20μ/ml) of the two drugs for 0.5, 1 and 2hr at 30°C and 37°C. The PAFE was determined by the difference in time (hr) required for growth of the control and test cultures to reach the 0.5 absorbance level after removal of the drug by dilution. The length of the PAFE was dependent upon the drug concentration, exposure time and temperature and the strain of C. albicans being assayed. Optimal PAFEs ranged from 3.7 to >17.0hr with cispentacin and from 1.7 to >21.0hr with pradimicin (BMY-28864).
- 日本医真菌学会の論文
日本医真菌学会 | 論文
- (1→3)-β-D-グルカン測定の問題点と進歩
- 両側の肺空洞病変にアスペルギルス感染を合併し抗真菌薬, ミカファンギンとイトラコナゾールの併用療法が有効であった Wegener 肉芽腫症の一例
- Trichophyton tonsurans 臨床分離株に対する各種抗真菌薬の in vitro 抗真菌活性
- 爪白癬の治療について : 日本医真菌学会標準化委員会提案2007
- Candida 属菌種のアゾール系薬感受性試験における現行の日本医真菌学会法, およびその改変法とNCCLS M27-A2法との相関性に関する検討